Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Advanced BioMedical Technologies, Inc. ABMT

Full chart Compare
Set alert

Price alert · ABMT

All alert types
0.00 USD 0.00 (+0.00%)

At closeNov 2, 2026, 4:00 PM EST

0.0002 Day range 0.0002
0.0002 52-week range 0.0005
YTD
+25.00%
1 year
+400.00%

Financial health

Altman Z-Score

-68.00 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -6.8×
FY 2013: -45.2×FY 2014: -29.5×FY 2015: -9.2×FY 2016: -18.3×FY 2017: -11.9×FY 2018: -15.3×FY 2019: -6.0×FY 2020: -15.6×FY 2021: -6.7×FY 2022: -6.8×
FY 2013 5y median -6.8× FY 2022
P/S 13.0×
FY 2013: 0.0×FY 2014: 0.0×FY 2015: 0.0×FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 358×FY 2020: 84.9×FY 2021: 28.7×FY 2022: 13.0×
FY 2013 5y median 28.7× FY 2022
P/B -0.4×
FY 2013: -13.7×FY 2014: -6.5×FY 2015: -1.8×FY 2016: -3.1×FY 2017: -1.6×FY 2018: -2.6×FY 2019: -0.6×FY 2020: -1.4×FY 2021: -0.6×FY 2022: -0.4×
FY 2013 5y median -0.6× FY 2022
P/FCF -4.8×
FY 2013: -65.5×FY 2014: -33.0×FY 2015: -9.3×FY 2016: -35.7×FY 2017: -14.7×FY 2018: -16.2×FY 2019: -5.5×FY 2020: 17.0×FY 2021: -5.5×FY 2022: -4.8×
FY 2013 5y median -5.5× FY 2022
EV/EBITDA -62.3×
FY 2013: -61.7×FY 2014: -47.1×FY 2015: -19.9×FY 2016: -36.8×FY 2017: -28.4×FY 2018: -29.7×FY 2019: -15.1×FY 2020: -53.2×FY 2021: -32.0×FY 2022: -62.3×
FY 2013 5y median -32.0× FY 2022
EV/Sales 38.1×
FY 2013: 0.0×FY 2014: 0.0×FY 2015: 0.0×FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 780×FY 2020: 122×FY 2021: 68.7×FY 2022: 38.1×
FY 2013 5y median 68.7× FY 2022
FCF Yield -20.8%
FY 2013: -1.5%FY 2014: -3.0%FY 2015: -10.7%FY 2016: -2.8%FY 2017: -6.8%FY 2018: -6.2%FY 2019: -18.2%FY 2020: 5.9%FY 2021: -18.2%FY 2022: -20.8%
FY 2013 5y median -18.2% FY 2022

Profitability

Gross Margin 81.9%
FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 34.8%FY 2020: 58.1%FY 2021: 54.5%FY 2022: 81.9%
FY 2013 5y median 54.5% FY 2022
Operating Margin -66.4%
FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: -5187.8%FY 2020: -361.4%FY 2021: -230.7%FY 2022: -66.4%
FY 2013 5y median -230.7% FY 2022
Net Margin -190.2%
FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: -8139.5%FY 2020: -543.7%FY 2021: -426.1%FY 2022: -190.2%
FY 2013 5y median -426.1% FY 2022
ROE 6.5%
FY 2013: 30.3%FY 2014: 22.1%FY 2015: 19.3%FY 2016: 16.6%FY 2017: 13.8%FY 2018: 17.0%FY 2019: 14.6%FY 2020: 9.1%FY 2021: 8.7%FY 2022: 6.5%
FY 2013 5y median 9.1% FY 2022
ROIC 16.0%
FY 2013: 226.3%FY 2014: 212.5%FY 2015: 63.0%FY 2016: 76.8%FY 2017: 32.9%FY 2018: 49.0%FY 2019: 38.7%FY 2020: 16.8%FY 2021: 26.4%FY 2022: 16.0%
FY 2013 5y median 26.4% FY 2022
ROA -130.3%
FY 2013: -451.5%FY 2014: -380.4%FY 2015: -520.3%FY 2016: -719.6%FY 2017: -809.4%FY 2018: -669.4%FY 2019: -434.2%FY 2020: -143.2%FY 2021: -162.6%FY 2022: -130.3%
FY 2013 5y median -162.6% FY 2022

Growth (YoY)

Revenue 58.3%
FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 960.2%FY 2021: 38.5%FY 2022: 58.3%
FY 2013 FY 2022
Operating Income 54.4%
FY 2013: -12.7%FY 2014: 14.1%FY 2015: 2.0%FY 2016: 23.8%FY 2017: 12.5%FY 2018: -57.1%FY 2019: 4.6%FY 2020: 26.1%FY 2021: 11.6%FY 2022: 54.4%
FY 2013 FY 2022
EPS (diluted) 29.8%
FY 2013: -17.2%FY 2014: 7.0%FY 2015: -4.1%FY 2016: 28.3%FY 2017: 7.3%FY 2018: -35.6%FY 2019: 27.0%FY 2020: 4.0%FY 2021: -8.3%FY 2022: 29.8%
FY 2013 FY 2022
Free Cash Flow 18.1%
FY 2013: 8.4%FY 2014: -20.9%FY 2015: -15.0%FY 2016: 56.2%FY 2017: -49.5%FY 2018: -60.7%FY 2019: 15.1%FY 2020: 180.9%FY 2021: -245.7%FY 2022: 18.1%
FY 2013 FY 2022

Financial Health

Current Ratio 0.0×
FY 2013: 0.0×FY 2014: 0.0×FY 2015: 0.0×FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×
FY 2013 5y median 0.0× FY 2022
Quick Ratio 0.0×
FY 2013: 0.0×FY 2014: 0.0×FY 2015: 0.0×FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×
FY 2013 5y median 0.0× FY 2022
Debt / Equity -0.9×
FY 2013: -0.9×FY 2014: -0.9×FY 2015: -0.8×FY 2016: -0.7×FY 2017: -0.8×FY 2018: -0.8×FY 2019: -0.8×FY 2020: -0.6×FY 2021: -0.8×FY 2022: -0.9×
FY 2013 5y median -0.8× FY 2022
Net Debt / EBITDA -41.0×
FY 2013: -3.7×FY 2014: -5.7×FY 2015: -6.0×FY 2016: -6.9×FY 2017: -8.9×FY 2018: -6.8×FY 2019: -8.2×FY 2020: -16.1×FY 2021: -18.6×FY 2022: -41.0×
FY 2013 5y median -16.1× FY 2022
Interest Coverage -0.5×
FY 2013: -4.5×FY 2014: -3.1×FY 2015: -2.5×FY 2016: -1.9×FY 2017: -1.6×FY 2018: -2.1×FY 2019: -1.9×FY 2020: -1.4×FY 2021: -1.2×FY 2022: -0.5×
FY 2013 5y median -1.4× FY 2022

Dividends

Dividend Yield 0.0%
FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2013 5y median 0.0% FY 2022
Payout Ratio 0.0%
FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2013 5y median 0.0% FY 2022

Annual · latest fiscal year ends 2022-10-31